Teladoc Health Debt-to-Equity Ratio Growth & History (TDOC)
Teladoc Health's debt-to-equity ratio was 0.75 for fiscal 2025.
View full Teladoc Health company overviewTeladoc Health annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.75 | 0.06 | +8.26% |
| 2024 | 2024-12-31 | 0.69 | 0.01 | +1.29% |
| 2023 | 2023-12-31 | 0.68 | −0.00 | −0.45% |
| 2022 | 2022-12-31 | 0.69 | 0.61 | +761.93% |
| 2021 | 2021-12-31 | 0.08 | −0.01 | −14.19% |
| 2020 | 2020-12-31 | 0.09 | −0.37 | −79.96% |
| 2019 | 2019-12-31 | 0.46 | 0.05 | +13.36% |
| 2018 | 2018-12-31 | 0.41 | 0.04 | +10.32% |
| 2017 | 2017-12-31 | 0.37 | 0.18 | +92.82% |
| 2016 | 2016-12-31 | 0.19 | 0.04 | +29.77% |
| 2015 | 2015-12-31 | 0.15 | — | — |
Teladoc Health quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.03 | −0.70 | −95.86% |
| Q1 2026 | 2026-03-31 | 0.78 | 0.05 | +6.99% |
| Q4 2025 | 2025-12-31 | 0.75 | 0.06 | +8.26% |
| Q3 2025 | 2025-09-30 | 0.75 | 0.06 | +8.71% |
| Q2 2025 | 2025-06-30 | 0.73 | 0.04 | +5.31% |
| Q1 2025 | 2025-03-31 | 0.73 | 0.03 | +4.50% |
| Q4 2024 | 2024-12-31 | 0.69 | 0.01 | +1.29% |
| Q3 2024 | 2024-09-30 | 0.69 | −0.00 | −0.21% |
| Q2 2024 | 2024-06-30 | 0.69 | 0.00 | +0.03% |
| Q1 2024 | 2024-03-31 | 0.69 | 0.00 | +0.43% |
| Q4 2023 | 2023-12-31 | 0.68 | −0.00 | −0.45% |
| Q3 2023 | 2023-09-30 | 0.69 | 0.43 | +162.94% |
| Q2 2023 | 2023-06-30 | 0.69 | 0.43 | +164.25% |
| Q1 2023 | 2023-03-31 | 0.69 | 0.52 | +298.78% |
| Q4 2022 | 2022-12-31 | 0.69 | 0.61 | +761.93% |
| Q3 2022 | 2022-09-30 | 0.26 | 0.18 | +231.08% |
| Q2 2022 | 2022-06-30 | 0.26 | 0.18 | +234.54% |
| Q1 2022 | 2022-03-31 | 0.17 | 0.08 | +95.45% |
| Q4 2021 | 2021-12-31 | 0.08 | −0.01 | −14.19% |
| Q3 2021 | 2021-09-30 | 0.08 | −0.36 | −82.16% |
| Q2 2021 | 2021-06-30 | 0.08 | −0.68 | −89.69% |
| Q1 2021 | 2021-03-31 | 0.09 | −0.39 | −81.60% |
| Q4 2020 | 2020-12-31 | 0.09 | −0.37 | −79.96% |
| Q3 2020 | 2020-09-30 | 0.44 | −0.02 | −5.02% |
| Q2 2020 | 2020-06-30 | 0.76 | 0.30 | +65.33% |
| Q1 2020 | 2020-03-31 | 0.48 | 0.03 | +7.70% |
| Q4 2019 | 2019-12-31 | 0.46 | 0.05 | +13.36% |
| Q3 2019 | 2019-09-30 | 0.47 | 0.07 | +17.63% |
| Q2 2019 | 2019-06-30 | 0.46 | −0.12 | −20.36% |
| Q1 2019 | 2019-03-31 | 0.45 | 0.07 | +17.25% |
| Q4 2018 | 2018-12-31 | 0.41 | 0.04 | +10.32% |
| Q3 2018 | 2018-09-30 | 0.40 | −0.06 | −13.09% |
| Q2 2018 | 2018-06-30 | 0.58 | 0.07 | +14.20% |
| Q1 2018 | 2018-03-31 | 0.38 | 0.26 | +209.17% |
| Q4 2017 | 2017-12-31 | 0.37 | 0.18 | +92.82% |
| Q3 2017 | 2017-09-30 | 0.46 | 0.27 | +149.27% |
| Q2 2017 | 2017-06-30 | 0.50 | 0.30 | +144.14% |
| Q1 2017 | 2017-03-31 | 0.12 | −0.04 | −22.16% |
| Q4 2016 | 2016-12-31 | 0.19 | 0.04 | +29.77% |
| Q3 2016 | 2016-09-30 | 0.18 | 0.04 | +30.33% |
| Q2 2016 | 2016-06-30 | 0.21 | — | — |
| Q1 2016 | 2016-03-31 | 0.16 | — | — |
| Q4 2015 | 2015-12-31 | 0.15 | — | — |
| Q3 2015 | 2015-09-30 | 0.14 | — | — |
Teladoc Health debt-to-equity ratio trends
Over the last five fiscal years, Teladoc Health's debt-to-equity ratio increased from 0.09 to 0.75, a change of 0.66. The latest reported quarter, Q2 2026, shows 0.03.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Teladoc Health source filings ↗